Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival (Q56986695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

title

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Susanna Mandruzzato

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Tilo Biedermann

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Graham Pawelec

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

37

Hans-Georg Rammensee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

33

Stefan Stevanovic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

6

Cezary Szczylik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

4

Romuald Zdrojowy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

9

Pierre-Yves Dietrich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Evelyna Derhovanessian

26

object named as

Evelyna Derhovanessian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

5

Anna Pluzanska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Steffen Walter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Toni Weinschenk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Arnulf Stenzl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Michael Staehler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Wolfram Brugger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Regina Mendrzyk

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Norbert Hilf

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Oliver Schoor

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Andrea Mahr

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Dominik Maurer

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Verona Vass

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Claudia Trautwein

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Peter Lewandrowski

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Christian Flohr

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Heike Pohla

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Janusz J Stanczak

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Vincenzo Bronte

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Hisakazu Yamagishi

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Tsuneharu Miki

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Fumiya Hongo

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Natsuki Takaha

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Kosei Hirakawa

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Hiroaki Tanaka

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Jürgen Frisch

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Andrea Mayer-Mokler

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Alexandra Kirner

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Carsten Reinhardt

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

Harpreet Singh-Jasuja

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

29 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1254-1261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

9 February 2020

cites work

1 reference

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma

21 January 2018

1 reference

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma

21 January 2018

1 reference

The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy

21 January 2018

1 reference

Metronomic cyclophosphamide regimen selectively depletes CD4 CD25 regulatory T cells and restores T and NK effector functions in end stage cancer patients

21 January 2018

1 reference

Cyclophosphamide decreases the number, percentage and the function of CD25 CD4 regulatory T cells, which suppress induction of contact hypersensitivity

21 January 2018

1 reference

Inhibition of CD4( )25 T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

21 January 2018

1 reference

Phenotypical and functional specialization of FOXP3 regulatory T cells

21 January 2018

1 reference

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

Pretreatment frequency of circulating IL-17 CD4 T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients

21 January 2018

1 reference

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

21 January 2018

1 reference

Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on Calibrated MHC/Anti-CD28-Coated Microspheres

21 January 2018

1 reference

Towards patient-specific tumor antigen selection for vaccination

21 January 2018

1 reference

Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: Interaction with HLA and T-cell receptor

21 January 2018

1 reference

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

21 January 2018

1 reference

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

21 January 2018

1 reference

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 T reg cells

21 January 2018

1 reference

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

21 January 2018

1 reference

IL4Ralpha myeloid-derived suppressor cell expansion in cancer patients.

21 January 2018

1 reference

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

21 January 2018

1 reference

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

21 January 2018

1 reference

Altered recognition of antigen is a mechanism of CD8 T cell tolerance in cancer

21 January 2018

1 reference

Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment

21 January 2018

1 reference

Thymic production of human FOXP3( ) regulatory T cells is stable but does not correlate with peripheral FOXP3 expression.

21 January 2018

1 reference

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

21 January 2018

1 reference

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

21 January 2018

1 reference

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

21 January 2018

1 reference

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

21 January 2018

1 reference

Serum lipoproteins and cancer

21 January 2018

1 reference

High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?

21 January 2018

1 reference

C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.

21 January 2018

1 reference

Orchestrating the orchestrators: chemokines in control of T cell traffic

21 January 2018

1 reference

CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma.

21 January 2018

1 reference

Immature dendritic cells (DCs) use chemokines and intercellular adhesion molecule (ICAM)-1, but not DC-specific ICAM-3-grabbing nonintegrin, to stimulate CD4 T cells in the absence of exogenous antigen

21 January 2018

1 reference

Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.

21 January 2018

1 reference

Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.

21 January 2018

1 reference

Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes

21 January 2018

1 reference

Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients

21 January 2018

1 reference

Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen

21 January 2018

1 reference

Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.

21 January 2018

1 reference

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

21 January 2018

1 reference

Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.

21 January 2018

1 reference

Immunogenicity and antitumor effects of vaccination with peptide vaccine /-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

21 January 2018

1 reference

Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens.

21 January 2018

1 reference

gp100(209-2M) peptide immunization of human lymphocyte antigen-A2 stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8 T cells

21 January 2018

1 reference

High frequencies of naive Melan-A/MART-1-specific CD8( ) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

21 January 2018

1 reference

Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen

21 January 2018

1 reference

The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8( ) T lymphocytes in IFN-gamma ELISPOT assays

21 January 2018

1 reference

MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma

21 January 2018

1 reference

High frequencies of functionally impaired cytokeratin 18-specific CD8 T cells in healthy HLA-A2 donors.

21 January 2018

1 reference

Optimizing a multicolor immunophenotyping assay

21 January 2018

1 reference

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

21 January 2018

1 reference

12 December 2020

Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules

1 reference

12 December 2020

The prevalence of Th17 cells in patients with gastric cancer

1 reference

12 December 2020

Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy

1 reference

12 December 2020

Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity

1 reference

12 December 2020

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8 T lymphocytes by structural and functional assays

1 reference

12 December 2020

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

12 December 2020

Rapid and strong human CD8 T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

1 reference

12 December 2020

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies

1 reference

12 December 2020

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

1 reference

12 December 2020

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

1 reference

12 December 2020

The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes

1 reference

12 December 2020

Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide.

1 reference

12 December 2020

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells

1 reference

12 December 2020

Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.2883

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22842478 AND SRC:MED&resulttype=core&format=json

9 February 2020

1 reference